E-drug: Re: Dipyrone
---------------------------------------------
Re: Dipyrone
India has banned all combination products containing Dipyrone
(prominent among these being Hoechst's Bralgan). However
single ingredient products are still available.
The ban came into force as a consequence of a Public Interest
Litigation filed in India's apex Court by three Consumer
organisations - National Campaign Committee for Drug Policy, All
India Drug Action Network and Drug Action Forum. The complaint
seeks to ban a large number of hazardous and irrational drugs,
and matters pertaining to a large number of drugs are still under
consideration.
Dr. Amit Sen Gupta
National Campaign Committee for Drug Policy,
India
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.